Cancer incidence and mortality in patients with insulin-treated diabetes: A UK cohort study

British Journal of Cancer

Volumn 92, Issue 11, 2005, Pages 2070-2075

  Swerdlow, A J ^a   Laing, S P ^a   Qiao, Z ^a   Slater, S D ^b   Burden, A C ^c   Botha, J L ^d   Waugh, N R ^e   Morris, A D ^f   Gatling, W ^g   Gale, E A ^h   Patterson, C C ⁱ   Keen, H ^j  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b VICTORIA INFIRMARY   (United Kingdom)

^c Heart of Birmingham Diabetes Care   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

^g POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^h SOUTHMEAD HOSPITAL   (United Kingdom)

ⁱ QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^j NONE   (United Kingdom)

more..

Author keywords

Cohort; Insulin treated diabetes

Indexed keywords

INSULIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STATISTICS; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; OVARY CANCER; PRIORITY JOURNAL; STANDARD MORTALITY RATIO; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE OF ONSET; ALCOHOL DRINKING; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INFANT; INFANT, NEWBORN; INSULIN; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; RISK FACTORS;

EID: 21244463817     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602611     Document Type: Article

References (44)

1. Adami H-O, Chow W-H, Nyrén O, Berne C, Linet MS, Ekbom A, Wolk A, McLaughlin JK, Fraumeni Jr JF (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88: 1472-1477
2. Adami H-O, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2: 307-314
3. Adler AI, Weiss NS, Kamb ML, Lyon JL (1996) Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States). Cancer Causes Control 7: 475-478
4. Andersson B, Mårin P, Lissner L, Vermeulen A, Björntorp P (1994) Testosterone concentrations in women and men with NIDDM. Diabetes Care 17:405-411
5. Andò S, Rubens R, Rottiers R (1984) Androgen plasma levels in male diabetics. J Endocrinol Invest 7: 21-24
6. Armstrong B, Lea AJ, Adelstein AM, Donovan JW, White GC, Ruttle S (1976) Cancer mortality and saccharin consumption in diabetics. Br J Prev Soc Med 30: 151-157
7. Aronson SM, Aronson BE (1965) Central nervous system in diabetes mellitus. Lowered frequency of certain intracranial neoplasms. Arch Neurol 12: 390-398
8. Breslow NE, Day NE (1987) Statistical Methods in Cancer Research. Volume II - The Design and Analysis of Cohort Studies. IARC Scientific Publication No. 82. Lyon: International Agency for Research on Cancer
9. Coker AL, Sanderson M, Zheng W, Fadden MK (2004) Diabetes mellitus and prostate cancer risk among older men: population-based case-control study. Br J Cancer 90: 2171-2175
10. Djursing H, Hagen C, Andersen AN, Svenstrup B, Bennett P, Pedersen LM (1985) Serum sex hormone concentrations in insulin dependent diabetic women with and without amenorrhoea. Clin Endocrinol 23: 147-154
11. Dorman JS, Steenkiste AR, Foley TP, Strotmeyer ES, Burke JP, Kuller LH, Kwoh CK (2001) Menopause in type 1 diabetic women. Is it premature? Diabetes 50: 1857-1862
12. Escobar-Morreale HF, Roldán B, Barrio R, Alonso M, Sancho J, de la Calle H, Garcia-Robles R (2000) High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 85: 4182-4187
13. Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273: 1605-1609
14. Grady D, Ernster VL (1996) Endometrial cancer. In Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni Jr JF (eds) 2nd edn. pp 1058-1089. New York: Oxford University Press
15. Green A, Jensen OM (1985) Frequency of cancer among insulin-treated diabetic patients in Denmark. Diabetologia 28: 128-130
16. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes - a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241: 471-475
17. International Agency for Research on Cancer (2002) Weight Control and Physical Activity. IARC Handbooks of Cancer Prevention, Vol. 6. Lyon: IARC
18. Kessler II (1970) Cancer mortality among diabetics. J Natl Cancer Inst 44: 673-686
19. Kjaer K, Hagen C, Sandø SH, Eshøj O (1992) Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab 75: 524-529
20. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70: 950-953
21. Laakso M, Pyörälä K (1985) Age of onset and type of diabetes. Diabetes Care 8: 114-117
22. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AWM, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H (1999) The British Diabetic Association Cohort Study, I: All-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16: 459-465
23. Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, McLaughlin JK, Nyren O, Adami HO (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42: 107-112
24. Meyer K, Deutscher J, Anil M, Berthold A, Bartsch M, Kiess W (2000) Serum androgen levels in adolescents with type 1 diabetes: relationship to pubertal stage and metabolic control. J Endocrinol Invest 23: 362-368
25. Moss SE, Klein R, Klein BEK (1991) Cause-specific mortality in a population-based study of diabetes. Am J Public Health 81: 1158-1162
26. Nyholm H, Djursing H, Hagen C, Agner T, Bennett P, Svenstrup B (1989) Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab 69: 946-949
27. O'Mara BA, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 38: 435-441
28. Ragozzino M, Melton III LJ, Chu C-P, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35: 13-19
29. Rajkhowa M, Glass MR, Rutherford AJ, Michelmore K, Balen AH (2000) Polycystic ovary syndrome: a risk factor for cardiovascular disease? Br J Obstet Gynaecol 107: 11-18
30. Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90: 1774-1786
31. Saukkonen T, Amin R, Williams RM, Fox C, Yuen KC, White MA, Umpleby AM, Acerini CL, Dunger DB (2004) Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes. J Clin Endocrinol Metab 89: 4634-4641
32. Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C (1996) Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88: 554-559
33. Swerdlow A, dos Santos Silva I, Doll R (2001) Cancer Incidence and Mortality in England and Wales: Trends and Risk Factors. Oxford: Oxford University Press
34. Swerdlow AJ, Laing SP, dos Santos Silva I, Slater SD, Burden AC, Botha JL, Waugh NR, Morris AD, Gatling W, Bingley PJ, Patterson CC, Qiao Z, Keen H (2004) Mortality of South Asian patients with insulin-treated diabetes mellitus in the United Kingdom: a cohort study. Diabet Med 21: 845-851
35. Verlato G, Zoppini G, Bonora E, Muggeo M (2003) Mortality from site-specific malignancies in Type 2 diabetic patients from Verona. Diabetes Care 26: 1047-1051
36. Weiderpass E, Gridley G, Persson I, Nyrén O, Ekbom A, Adami H-O (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71: 360-363
37. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA (2000) Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 11: 185-192
38. Weiderpass E, Ye W, Vainio H, Kaaks R, Adami H-O (2002a) Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer 102: 258-261
39. Weiderpass E, Ye W, Vainio H, Kaaks R, Adami HO (2002b) Diabetes mellitus and ovarian cancer (Sweden). Cancer Causes Control 13: 759-764
40. Weiss NS, Cook LS, Farrow DC, Rosenblatt KA (1996) Ovarian cancer. In Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni Jr JF (eds) 2nd edn, pp 1040-1057. New York: Oxford University Press
41. Wideroff L, Gridley G, Mellemkjaer L, Chow W-H, Linet M, Keehn S, Borch-Johnsen K, Olsen JH (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89: 1360-1365
42. Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147: 816-825
43. World Health Organization (1977) Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Ninth Revision. Geneva: World Health Organization
44. Zahm SH, Blair A, Cantor KP, Fraumeni Jr JF (1995) Non-insulin dependent diabetes mellitus and non-Hodgkin's lymphoma. Other American studies fail to confirm an association. BMJ 310: 1009-1010